Patents by Inventor Toshiharu Narita
Toshiharu Narita has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20190073925Abstract: An imaging phantom according to the present invention includes a main body having an optical characteristic simulating an optical characteristic of biological tissue and a structure (3) installed in the main body, the structure having a fractal structure simulating a tissue structure having a fractal nature present in the biological tissue.Type: ApplicationFiled: November 2, 2018Publication date: March 7, 2019Applicant: OLYMPUS CORPORATIONInventors: Yuki SHONO, Ryosuke ITO, Toshiharu NARITA, Hideyuki TAKAOKA
-
Patent number: 9055866Abstract: There is provided an inside observation apparatus of an endoscope and the like which can perform an inside observation for irradiating an illumination light to a minute area of a surface of an object (for example, a living tissue) having a light scattering property and detecting a back-scattered light of the illumination light, can increase a detected light amount by a simply and low cost configuration by making an area of a detection region larger than an illumination region, and can reduce a time necessary to detect an body (for example, a blood vessel) to be observed and detect a region deeper than a conventional region.Type: GrantFiled: December 27, 2010Date of Patent: June 16, 2015Assignee: OLYMPUS CORPORATIONInventors: Toshiharu Narita, Ken Fujinuma, Ryosuke Ito, Kenji Taira, Hideyuki Takaoka, Shinichi Takimoto, Hiroyuki Nishida, Hiroya Fukuyama
-
Publication number: 20110263955Abstract: There is provided an inside observation apparatus of an endoscope and the like which can perform an inside observation for irradiating an illumination light to a minute area of a surface of an object (for example, a living tissue) having a light scattering property and detecting a back-scattered light of the illumination light, can increase a detected light amount by a simply and low cost configuration by making an area of a detection region larger than an illumination region, and can reduce a time necessary to detect an body (for example, a blood vessel) to be observed and detect a region deeper than a conventional region.Type: ApplicationFiled: December 27, 2010Publication date: October 27, 2011Applicant: OLYMPUS CORPORATIONInventors: Toshiharu Narita, Ken Fujinuma, Ryosuke Ito, Kenji Taira, Hideyuki Takaoka, Shinichi Takimoto, Hiroyuki Nishida, Hiroya Fukuyama
-
Patent number: 7358205Abstract: An alkali-free glass substrate containing, by mass percent, 50-70% of SiO2, 10-25% of Al2O3, 5-20% of B2O3, 0-10% of MgO, 0-15% of CaO, 0-10% of BaO, 0-10% of SrO and 0-5% of ZnO, also containing SnO2 and/or Sb2O3 and having a ?-OH value of at least 0.485/mm.Type: GrantFiled: September 1, 2004Date of Patent: April 15, 2008Assignee: Nippon Electric Glass Co., Ltd.Inventors: Toshiharu Narita, Tatsuya Takaya, Masahiro Tomamoto
-
Patent number: 6933253Abstract: An alkali-free glass applicable to a light transparent glass substrate in a liquid crystal display essentially consists, by weight, of basic elements of 40-70% SiO2, 6-25% Al2O3, 5-20% B2O3, 0-10% MgO, 0-15% CaO, 0-30% BaO, 0-10% SrO, and 0-10% ZnO, and a fining agent of a combination of 0.05-3% Sb2O3 and at least one of 0.05-2% SnO2 and 0.005-1% Cl2, which fining agent makes the resultant glass free from bubbles without the use of toxic As2O3 which has been known as the fining agent in the art.Type: GrantFiled: November 18, 2002Date of Patent: August 23, 2005Assignee: Nippon Electric Glass Co., Ltd.Inventors: Jun Naka, Toshiharu Narita, Shinkichi Miwa, Shigeru Yamamoto
-
Publication number: 20050065014Abstract: An alkali-free glass substrate containing, by mass percent, 50-70% of SiO2, 10-25% of Al2O3, 5-20% of B2O3, 0-10% of MgO, 0-15% of CaO, 0-10% of BaO, 0-10% of SrO and 0-5% of ZnO, also containing SnO2 and/or Sb2O3 and having a B-OH value of at least 0.485/mm.Type: ApplicationFiled: September 1, 2004Publication date: March 24, 2005Inventors: Toshiharu Narita, Tatsuya Takaya, Masahiro Tomamoto
-
Publication number: 20030121288Abstract: An alkali-free glass applicable to a light transparent glass substrate in a liquid crystal display essentially consists, by weight, of basic elements of 40-70% SiO2, 6-25% Al2O3, 5-20% B2O3, 0-10% MgO, 0-15% CaO, 0-30% BaO, 0-10% SrO, and 0-10% ZnO, and a fining agent of a combination of 0.05-3% Sb2O3 and at least one of 0.05-2% SnO2 and 0.005-1% Cl2, which fining agent makes the resultant glass free from bubbles without the use of toxic As2O3 which has been known as the fining agent in the art.Type: ApplicationFiled: November 18, 2002Publication date: July 3, 2003Applicant: NIPPON ELECTRIC GLASS CO., LTD.Inventors: Jun Naka, Toshiharu Narita, Shinkichi Miwa, Shigeru Yamamoto
-
Patent number: 6546753Abstract: An alkali-free glass applicable to a light transparent glass substrate in a liquid crystal display essentially consists, by weight, of basic elements of 40-70% SiO2, 6-25% Al2O3, 5-20% B2O3, 0-10% MgO, 0-15% CaO, 0-30% BaO, 0-10% SrO, and 0-10% ZnO, and a fining agent of a combination of 0.05-3% Sb2O3 and at least one of 0.05-2% SnO2 and 0.005-1% Cl2, which fining agent makes the resultant glass free from bubbles without the use of toxic As2O3 which has been known as the fining agent in the art.Type: GrantFiled: July 17, 2001Date of Patent: April 15, 2003Assignee: Nippon Electric Glass Co. Ltd.Inventors: Jun Naka, Toshiharu Narita, Shinkichi Miwa, Shigeru Yamamoto
-
Patent number: 6508083Abstract: An alkali-free glass applicable to a light transparent glass substrate in a liquid crystal display essentially consists, by weight, of basic elements of 40-70% SiO2, 6-25% Al2O3, 5-20% B2O3, 0-10% MgO, 0-15% CaO, 0-30% BaO, 0-10% SrO, and 0-10% ZnO, and a fining agent of a combination of 0.05-3% Sb2O3 and at least one of 0.05-2% SnO2 and 0.005-1% Cl2, which fining agent makes the resultant glass free from bubbles without the use of toxic As2O3 which has been known as the fining agent in the art.Type: GrantFiled: August 20, 1997Date of Patent: January 21, 2003Assignee: Nippon Electric Glass Co., Ltd.Inventors: Jun Naka, Toshiharu Narita, Shinkichi Miwa, Shigeru Yamamoto
-
Patent number: 6468933Abstract: An alkali-free glass essentially consists of, by weight percent, 40-70% SiO2, 6-25% Al2O3, 5-20% B2O3, 0-10% MgO, 0-15% CaO, 0-30% BaO, 0-10% SrO, 0-10% ZnO, 0.05-2% SnO2, and 0.005-1% Cl2, and substantially contains no alkali metal oxide.Type: GrantFiled: September 21, 1999Date of Patent: October 22, 2002Assignee: Nippon Electric Glass Co., Ltd.Inventors: Toshiharu Narita, Hiroki Yamazaki
-
Publication number: 20020011080Abstract: An alkali-free glass applicable to a light transparent glass substrate in a liquid crystal display essentially consists, by weight, of basic elements of 40-70% SiO2, 6-25% Al2O3, 5-20% B2O3, 0-10% MgO, 0-15% CaO, 0-30% BaO, 0-10% SrO, and 0-10% ZnO, and a fining agent of a combination of 0.05-3% Sb2O3 and at least one of 0.05-2% SnO2 and 0.005-1% Cl2, which fining agent makes the resultant glass free from bubbles without the use of toxic As2O3 which has been known as the fining agent in the art.Type: ApplicationFiled: July 17, 2001Publication date: January 31, 2002Applicant: NIPPON ELECTRIC GLASS CO., LTD.Inventors: Jun Naka, Toshiharu Narita, Shinkichi Miwa, Shigeru Yamamoto
-
Patent number: 5393889Abstract: A pharmaceutically-acceptable acid addition salt of a bis-dioxopiperazine derivative of the formula (I): ##STR1## which derivative exhibits anti-tumor potency and is water-soluble, wherein R.sup.1 is a C.sub.1-6 alkyl group,R.sup.2 represents a hydrogen atom or: ##STR2## R.sup.3 represents a hydrogen atom, a C.sub.1-6 alkyl group or (CH.sub.2).sub.n A, wherein A respresents carboxyl, benzyloxycarbonyl, mercapto, amino, benzyloxycarbonylamino or: ##STR3## and n is an integer of 1, 2, 3 or 4, and R.sup.4 represents a hydrogen atom or is coupled with R.sup.3 into a 5-membered ring, which may contain one sulfur atom as an additional ring heteroatom.Type: GrantFiled: March 2, 1992Date of Patent: February 28, 1995Assignee: Zenyaku Kogyo Kabushiki KaishaInventors: Muneaki Takase, Toshiharu Narita, Toshihiko Komatsu
-
Patent number: 4785405Abstract: The power system stabilizer is provided at an individual power system to be separated due to an accident cutting off a link line which interconnects a number of power systems to form a large-scale power system. The power systems include power stations such as power plants and transformer substations. A simplified arithmetic processing unit of the stabilizer performs an arithmetic processing by a simple linear equation using an output frequency of a representative power station belonging to the separated power system immediately after the accident has been cleared, so that a total load drop of the separated power system can be assumed. Based on the assumption amount, balance control of demand and supply in the separated system is made.Type: GrantFiled: January 5, 1987Date of Patent: November 15, 1988Assignees: Chubu Electric Power Company, Inc., Mitsubishi Denki Kabushiki KaishaInventors: Taizo Hasegawa, Hirotaka Ono, Isao Koda, Tadahiro Gouda, Hideharu Oshida, Toshiharu Narita
-
Patent number: 4452786Abstract: Novel condurango glycoside compounds, antitumor agents comprising them and processes for their preparation, compositions containing them and methods of treating tumor with them are disclosed herein in which the novel condurango glycoside compounds are represented by the following formula (I): ##STR1## where X together with the 13 and 14 position carbon atoms is a group selected from the group consisting of ##STR2##Type: GrantFiled: November 2, 1981Date of Patent: June 5, 1984Assignee: Zenyaku Kogyo Kabushiki KaishaInventors: Hiroshi Mitsuhashi, Den-ichi Mizuno, Koji Hayashi, Shigeru Abe, Muneaki Takase, Toshiharu Narita
-
Patent number: 4320120Abstract: New extracts of Marsdenia cundurango Reichenbach fil., processes for preparing them, antitumor agents comprising them, compositions containing them and methods of treating tumor with them are described herein in which the extracts consist essentially of the portion of Marsdenia cundurango Reichenbach fil. which is soluble in lower alcohols and in chlorinated hydrocarbons other than carbon tetrachloride and insoluble in carbon tetrachloride or aromatic hydrocarbons.Type: GrantFiled: August 18, 1980Date of Patent: March 16, 1982Assignee: Zenyaku Kogyo Kabushiki KaishaInventors: Hiroshi Mitsuhashi, Den-ichi Mizuno, Koji Hayashi, Shigeru Abe, Muneaki Takase, Toshiharu Narita